Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Do patients with prediabetes share the same vascular complication risk seen in patients with T2D?
Read More »Associations between Prediabetes and Vascular Complications
Old vs. New: Which T2D Agents Have the Best Renal Outcomes?
How do DPP-4 inhibitors and sulfonylureas compare to SGLT2is and GLP-1 agonists regarding renal outcomes?
Read More »The VERTIS CV Study – SGLT-2 Inhibitors’ Cardiovascular and Renal Outcomes in T2D
This article is part of a live interview with Dr. Engel, Associate Vice President, Cardiometabolic and Women's Health, Merck Research Laboratories.
Read More »Live Longer and Cardiovascular Disease-Free
How many years can semaglutide add to your life?
Read More »Common Diabetes Drug Linked To Lower Dementia Rates
One of the most commonly prescribed medications worldwide may have a hidden benefit.
Read More »Once-A-Week Insulin Will Happen
The end to every day insulin use may be in sight.
Read More »Low Carbohydrate Diets the Future for Weight Loss in Obesity
Is a very low carbohydrate diet (VLCD) superior to an essential carbohydrate/low-fat diet (LFD) for improving body mass and insulin sensitivity?
Read More »SGLT-2 vs. GLP-1: Cardiovascular Outcomes in Adults with Type 2 Diabetes
Cardiovascular events decline for patients using which antidiabetic medication?
Read More »Dulaglutide Provides CVD Protection with or without Metformin
Data from the REWIND trial suggest that dulaglutide has cardioprotective properties.
Read More »Diabetes and Subsequent Weight Loss Linked to an Increased Risk of Pancreatic Cancer
The case for expanding screening for pancreatic cancer in those with new onset of diabetes and weight loss.
Read More »